Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Oct 24, 2020 at 6:19 AM EDT

France Becomes 7th Nation To Top One Million Cases

According to the Bing COVID-19 Tracker, global confirmed cases of the disease reached 42,214,376 today, up by 501,062 from the…

Chris Lange | Oct 23, 2020 at 12:56 PM EDT

Why BlondVax Pharma Is Getting Absolutely Crushed

BlondVax Pharma was absolutely crushed on Friday after the company reported late-stage results from its flu vaccine study. Needless to…

Chris Lange | Oct 23, 2020 at 10:20 AM EDT

Gilead Is the First COVID-19 Stock to Win FDA Approval

Gilead Sciences is the first company to cross the finish line for regulatory approval in the fight against the coronavirus.

Douglas A. McIntyre | Oct 23, 2020 at 8:20 AM EDT

The 40 Counties Where More Than 1,000 Americans Have Died From COVID-19

As the third wave of COVID-19 continues through the rest of this year and perhaps into early 2021, it is…

Douglas A. McIntyre | Oct 22, 2020 at 7:24 AM EDT

COVID-19: This Is the Deadliest County in America

As the COVID-19 spreads again, more and more counties are likely to see higher case and death figures than they…

Chris Lange | Oct 21, 2020 at 9:50 AM EDT

The Good, the Bad, the Ugly of Biogen’s Q3

Biogen reported better than expected third-quarter financial results with disappointing guidance before the markets opened on Wednesday.

Douglas A. McIntyre | Oct 21, 2020 at 9:10 AM EDT

Bing COVID-19 Tracker (10/21): Argentina the Fifth Nation With 1 Million Cases

According to the Bing COVID-19 Tracker, global confirmed cases of the disease reached 40.6 million.

Douglas A. McIntyre | Oct 21, 2020 at 8:03 AM EDT

These Are the 358 Counties Where No One Has Died From COVID-19

COVID-19 has killed almost 225,000 people in America. Some academic and government models forecast the spread of the disease will…

Chris Lange | Oct 20, 2020 at 11:24 AM EDT

Why This Midstage PTSD Study Is the Real Deal

Aptinyx shares soared on Tuesday after the company provided an update from its midstage study in post-traumatic stress disorder.

Chris Lange | Oct 19, 2020 at 12:18 PM EDT

What Analysts Are Saying About GoodRx After the Quiet Period

The post-IPO quiet period for GoodRx is over, and now analysts are rushing to make calls on the stock. For the…

Chris Lange | Oct 19, 2020 at 10:53 AM EDT

Are BioSpecifics Shareholders Getting Enough in the Endo Buyout?

Are BioSpecific Technologies shareholders actually getting a good deal from the merger agreement with Endo International?

Chris Lange | Oct 19, 2020 at 9:54 AM EDT

A Look at the FDA’s Most Recent COVID-19 Approval

OraSure Technologies shares jumped to start off the week after the company announced an update from the FDA in regards…

Douglas A. McIntyre | Oct 19, 2020 at 7:45 AM EDT

July 16 Remains the Day COVID-19 Hit America the Hardest

The number of confirmed COVID-19 cases in the United States recently has risen so much that the county has entered…

Chris Lange | Oct 17, 2020 at 8:40 AM EDT

7 Large Biotechs Expected to Outperform This Earnings Season

Earnings season is upon us and investors are pining for information about which stocks and sectors will do well. After…

Chris Lange | Oct 16, 2020 at 10:46 AM EDT

What’s the Next Step for Pfizer and BioNTech’s Coronavirus Vaccine?

While other companies seem to be struggling with their coronavirus vaccines, Pfizer and BioNTech are just picking up speed. Pfizer’s…

1 … 36 37 38 39 40 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

France Becomes 7th Nation To Top One Million Cases

Why BlondVax Pharma Is Getting Absolutely Crushed

Gilead Is the First COVID-19 Stock to Win FDA Approval

The 40 Counties Where More Than 1,000 Americans Have Died From COVID-19

COVID-19: This Is the Deadliest County in America

The Good, the Bad, the Ugly of Biogen’s Q3

Bing COVID-19 Tracker (10/21): Argentina the Fifth Nation With 1 Million Cases

These Are the 358 Counties Where No One Has Died From COVID-19

Why This Midstage PTSD Study Is the Real Deal

What Analysts Are Saying About GoodRx After the Quiet Period

Are BioSpecifics Shareholders Getting Enough in the Endo Buyout?

A Look at the FDA’s Most Recent COVID-19 Approval

July 16 Remains the Day COVID-19 Hit America the Hardest

7 Large Biotechs Expected to Outperform This Earnings Season

What’s the Next Step for Pfizer and BioNTech’s Coronavirus Vaccine?

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Rivian Tops Q1 Estimates, but Investors Investors Rightly Remain Wary

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Health and Healthcare Articles

All Health and Healthcare Articles

France Becomes 7th Nation To Top One Million Cases

Why BlondVax Pharma Is Getting Absolutely Crushed

Gilead Is the First COVID-19 Stock to Win FDA Approval

The 40 Counties Where More Than 1,000 Americans Have Died From COVID-19

COVID-19: This Is the Deadliest County in America

The Good, the Bad, the Ugly of Biogen’s Q3

Bing COVID-19 Tracker (10/21): Argentina the Fifth Nation With 1 Million Cases

These Are the 358 Counties Where No One Has Died From COVID-19

Why This Midstage PTSD Study Is the Real Deal

What Analysts Are Saying About GoodRx After the Quiet Period

Are BioSpecifics Shareholders Getting Enough in the Endo Buyout?

A Look at the FDA’s Most Recent COVID-19 Approval

July 16 Remains the Day COVID-19 Hit America the Hardest

7 Large Biotechs Expected to Outperform This Earnings Season

What’s the Next Step for Pfizer and BioNTech’s Coronavirus Vaccine?

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Rivian Tops Q1 Estimates, but Investors Investors Rightly Remain Wary

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts